Synthesis and DHFR inhibitory activity of a series of 6-substituted-2,4-diaminothieno[2,3-d]pyrimidines

被引:41
作者
Donkor, IO
Li, H
Queener, SF
机构
[1] Univ Tennessee, Ctr Hlth Sci, Dept Pharmaceut Sci, Memphis, TN 38163 USA
[2] Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA
关键词
Pneumocystis carinii; pneumonia; DHFR; diaminothieno[2,3-d]pyrimidines; opportunistic infections;
D O I
10.1016/S0223-5234(03)00101-6
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of 6-aralkyl substituted 2,4-diaminothieno[2,3-d]pyrimidines in which the 6-aryl group is separated from the thieno[2,3-d]pyrimidine ring by two to five methylene groups were synthesized and studied as inhibitors of dihydrofolate reductase from Pneumocystis carinii, Toxoplasma gondii, Mycobacterium avium, and rat liver. Compounds in which the thieno[2,3-d]pyrimidine ring is separated from the 6-aryl substituent by three methylene groups were the most potent inhibitors of the series (with IC50 values ranging from 0.24 and 11.0 muM) but those with two methylene groups between the aromatic rings were the most selective agents. (C) 2003 Editions scientifiques et medicales Elsevier SAS. All rights reserved.
引用
收藏
页码:605 / 611
页数:7
相关论文
共 22 条
[1]   PNEUMOCYSTIS-CARINII DIHYDROFOLATE-REDUCTASE USED TO SCREEN POTENTIAL ANTIPNEUMOCYSTIS DRUGS [J].
BROUGHTON, MC ;
QUEENER, SF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (07) :1348-1355
[2]   IDENTIFICATION OF HIGHLY POTENT AND SELECTIVE INHIBITORS OF TOXOPLASMA-GONDII DIHYDROFOLATE-REDUCTASE [J].
CHIO, LC ;
QUEENER, SF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (09) :1914-1923
[3]   FOLATE ANTAGONISTS .6. SYNTHESIS AND ANTIMALARIAL EFFECTS OF FUSED "2,4-DIAMINOTHIENO[2,3-D]PYRIMIDINES [J].
ELSLAGER, EF ;
JACOB, P ;
WERBEL, LM .
JOURNAL OF HETEROCYCLIC CHEMISTRY, 1972, 9 (04) :775-&
[4]  
FLORIDIA M, 2000, HIV MED, V3, P75
[5]   The incidence and spectrum of AIDS-defining illnesses in persons treated with antiretroviral drugs [J].
Forrest, DM ;
Seminari, E ;
Hogg, RS ;
Yip, B ;
Raboud, J ;
Lawson, L ;
Phillips, P ;
Schechter, MT ;
O'Shaughnessy, MV ;
Montaner, JSG .
CLINICAL INFECTIOUS DISEASES, 1998, 27 (06) :1379-1385
[6]   Selective Pneumocystis carinii dihydrofolate reductase inhibitors:: Design, synthesis, and biological evaluation of new 2,4-diamino-5-substituted-furo[2,3-d]pyrimidines [J].
Gangjee, A ;
Guo, X ;
Queener, SF ;
Cody, V ;
Galitsky, N ;
Luft, JR ;
Pangborn, W .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (08) :1263-1271
[7]   Drug treatment of HIV-related opportunistic infections [J].
Klepser, ME ;
Klepser, TB .
DRUGS, 1997, 53 (01) :40-73
[8]   Features of AIDS and AIDS defining diseases during the highly active antiretroviral therapy (HAART) era, compared with the pre-HAART period: a case-control study [J].
Manfredi, R ;
Chiodo, F .
SEXUALLY TRANSMITTED INFECTIONS, 2000, 76 (02) :145-146
[9]  
Manfredi R, 2001, EUR J CLIN MICROBIOL, V20, P410
[10]   Mycoses associated with AIDS in the Third World [J].
Marques, SA ;
Robles, AM ;
Tortorano, AM ;
Tuculet, MA ;
Negroni, R ;
Mendes, RP .
MEDICAL MYCOLOGY, 2000, 38 :269-279